16 jan ,2019

Vacancy for a PhD in Analytical Sciences

We are looking for a PhD in Analytical Sciences. About Ardena Ardena is a reputed contract partner providing drug substance and drug product development, manufacturing, logistics and bioanalytical services to pharmaceutical customers globally. In parallel, we compile the regulatory dossier for our customers to fast track their product towards compliance. Ardena has a niche expertise […]

READ MORE
27 dec ,2018

BSc-MSc Nano medicines R&D

We are looking for a chemist (BSc or MSc) to strengthen our Process R&D team for nanomedicines. About Ardena Ardena is a reputed contract partner providing drug substance and drug product development, manufacturing, logistics and bioanalytical services to pharmaceutical customers globally. In parallel, we compile the regulatory dossier for our customers to fast track their […]

READ MORE

Older news

18 dec ,2018

Synthesespecialist peptiden (HBO niveau)

Ardena verleent services op het gebied van drug substance en drug product development, productie, logistiek en bioanalyse ten behoeve van de farmaceutische industrie. Daarnaast leveren wij een bijdrage aan het opstellen van het registratiedossier voor onze klanten. Op deze manier stellen we hen in staat om zo snel mogelijk door het ontwikkelingstraject van hun geneesmiddel te […]

Further reading >
27 sep ,2018

Vacancy BSc Analytical Sciences

We are looking for an analytical chemist (BSc) to strengthen our Analytical Sciences team. About Ardena Ardena is a reputed contract partner providing drug substance and drug product development, manufacturing, logistics and bioanalytical services to pharmaceutical customers globally. In parallel, we compile the regulatory dossier for our customers to fast track their product towards compliance. […]

Further reading >
06 sep ,2018

Vacancy for a PhD in Organic Synthesis

We are looking for a synthetic organic chemist (PhD) to strengthen our process R&D team for small molecules. Ardena is a reputed contract partner providing drug substance and drug product development, manufacturing, logistics and bioanalytical services to pharmaceutical customers globally. In parallel, we compile the regulatory dossier for our customers to fast track their product […]

Further reading >
07 jun ,2018

Pivot Park is one of the fastest growing campuses in the Netherlands

With a growth of 57% in employment between 2014 and 2018, Pivot Park is one of the fastest growing campuses in the Netherlands. This became evident from a recently published report by Buck Consultants International. The researchers conclude that things are going well with the campuses in the Netherlands. They are a popular location and […]

Further reading >
14 mrt ,2018

Ardena Group acquires ChemConnection

We are pleased to announce that ChemConnection has become part of the Ardena Group.  Joining Ardena enables us to become your one source contractor for all chemical, pharmaceutical and (bio)analytical needs that arise in the clinical supply chain. We believe that by joining forces, substantial benefits will be created, reducing your project risks and shortening […]

Further reading >
07 dec ,2017

Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials. Click here for press release.

Further reading >
06 sep ,2016

Austin Chemical Company, Syncom, and ChemConnection announce partnership and establish joint venture SynConnection LLC

BUFFALO GROVE (IL, USA), GRONINGEN (The Netherlands), OSS (The Netherlands), 6 September 2016 – Austin Chemical Company Inc, a pharmaceutical procurement and logistics service provider announced today the joint venture with Syncom BV, a pharmaceutical contract synthesis company, and ChemConnection BV, a GMP licensed contact manufacturing company. The development of novel active pharmaceutical ingredients (NCEs, […]

Further reading >
16 jun ,2016

CHEMCONNECTION AND CRISTAL THERAPEUTICS ANNOUNCE SUCCESSFUL GMP PRODUCTION OF CRIPEC® DOCETAXEL FOR PHASE 1/2A CLINICAL TRIALS

Oss and Maastricht, The Netherlands, June 1, 2016 – ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences company developing nanomedicines against cancer and other diseases. “ChemConnection has made a tremendous leap forward in becoming the […]

Further reading >
Menu
class="last-menu-item menu-itemve-menu" class="">
  • Drug Substances
  • Nanomedicines
  • Analytical Sciences
  • About us
  • Contact